Skip to main content
AbbVie Inc. (ABBV)
NYSE: ABBV · IEX Real-Time Price · USD
166.42
+2.07 (1.26%)
At close: May 17, 2024, 4:00 PM
166.70
+0.28 (0.17%)
Pre-market: May 20, 2024, 9:04 AM EDT

AbbVie Revenue

AbbVie had revenue of $54.40B in the twelve months ending March 31, 2024, down -4.12% year-over-year. Revenue in the quarter ending March 31, 2024 was $12.31B with 0.70% year-over-year growth. In the year 2023, AbbVie had annual revenue of $54.32B, a decrease of -6.44%.

Revenue (ttm)
$54.40B
Revenue Growth
-4.12%
P/S Ratio
5.40
Revenue / Employee
$1,088,060
Employees
50,000
Market Cap
293.88B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202354.32B-3.74B-6.44%
Dec 31, 202258.05B1.86B3.30%
Dec 31, 202156.20B10.39B22.69%
Dec 31, 202045.80B12.54B37.69%
Dec 31, 201933.27B513.00M1.57%
Dec 31, 201832.75B4.54B16.08%
Dec 31, 201728.22B2.58B10.06%
Dec 31, 201625.64B2.78B12.16%
Dec 31, 201522.86B2.90B14.52%
Dec 31, 201419.96B1.17B6.23%
Dec 31, 201318.79B410.00M2.23%
Dec 31, 201218.38B936.00M5.37%
Dec 31, 201117.44B1.81B11.55%
Dec 31, 201015.64B1.42B10.02%
Dec 31, 200914.21B--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 379.49B
Johnson & Johnson 81.80B
Merck & Co. 61.40B
Novartis AG 49.92B
AstraZeneca 47.61B
Thermo Fisher 42.49B
Abbott Laboratories 40.33B
Eli Lilly 35.93B
Revenue Rankings

ABBV News

More News